Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia
Sponsor
Ajou University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06123637
Collaborator
(none)
68
2
11.9
Study Details
Study Description
Brief Summary
The primary purpose of this study is to compare the analgesia nociception index-guided anesthesia and standard anesthesia on remifentanil requirement in desflurane anesthesia.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comparison of Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia on Remifentanil Requirement in Desflurane Anesthesia
Anticipated Study Start Date
:
Jan 2, 2024
Anticipated Primary Completion Date
:
Dec 30, 2024
Anticipated Study Completion Date
:
Dec 30, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Analgesia nociception index group
|
Behavioral: Analgesia nociception index-guided anesthesia
Maintaining the blood pressure based on analgesia nociception index of >50 value
|
| Placebo Comparator: Standard group
|
Behavioral: Standard anesthesia
Maintaining the blood pressure based on anesthesiologist's decision
|
Outcome Measures
Primary Outcome Measures
- Remifentanil requirement [at time of the end of skin suture (up to 4 hours)]
Assessing the total dose of remifentanil administered from skin incision until skin suture
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Clinical diagnosis of gastric cancer
Exclusion Criteria:
-
Conversion to open laparotomy
-
Prior opioid abuse
-
Prior infection
-
Cardiac arrythmia
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Ajou University School of Medicine
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ji Eun Kim,
Assistant professor,
Ajou University School of Medicine
ClinicalTrials.gov Identifier:
NCT06123637
Other Study ID Numbers:
- AJOUIRB-IV-2023-389
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: